Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andreia Bettencourt
Ustekinumab in Real-Life Practice: Experience in 116 Patients With Moderate-To-Severe Psoriasis
Acta Medica Portuguesa
Medicine
Related publications
Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-To-Severe Psoriasis in the US Corrona Psoriasis Registry
Journal of Dermatological Treatment
Dermatology
The Experience of Pain and Redness in Patients With Moderate to Severe Plaque Psoriasis
Journal of Dermatological Treatment
Dermatology
Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)
British Journal of Dermatology
Dermatology
Medicine
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Effectiveness of Resuming Ustekinumab Therapy in Psoriasis Patients With Metabolic Disorders. Clinical Experience
Vestnik dermatologii i venerologii
Pss17 - Cost Per Responder Analysis of Brodalumab Compared With Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Canada
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Characterization of Insufficient Responders to Anti-Tumor Necrosis Factor Therapies in Patients With Moderate to Severe Psoriasis: Real-World Data From the US Corrona Psoriasis Registry
Journal of Dermatological Treatment
Dermatology
